Concepts (276)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Syncytial Virus, Human | 27 | 2025 | 234 | 4.460 |
Why?
|
| Respiratory Syncytial Virus Infections | 31 | 2025 | 382 | 4.450 |
Why?
|
| Viral Load | 9 | 2025 | 406 | 1.820 |
Why?
|
| Nasal Mucosa | 2 | 2025 | 83 | 1.710 |
Why?
|
| Organoids | 4 | 2025 | 307 | 1.650 |
Why?
|
| Cytokines | 3 | 2025 | 1348 | 1.190 |
Why?
|
| Respiratory Tract Infections | 7 | 2025 | 293 | 1.040 |
Why?
|
| Virus Replication | 7 | 2025 | 597 | 1.040 |
Why?
|
| Respiratory Syncytial Viruses | 5 | 2025 | 153 | 0.890 |
Why?
|
| RNA, Viral | 8 | 2024 | 513 | 0.870 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 6 | 2025 | 77 | 0.800 |
Why?
|
| Viral Fusion Proteins | 9 | 2023 | 74 | 0.780 |
Why?
|
| Antibodies, Viral | 14 | 2025 | 1169 | 0.740 |
Why?
|
| Bacterial Adhesion | 3 | 2007 | 104 | 0.720 |
Why?
|
| Picornaviridae Infections | 4 | 2025 | 50 | 0.710 |
Why?
|
| Transplant Recipients | 3 | 2021 | 234 | 0.660 |
Why?
|
| Respiratory Mucosa | 3 | 2020 | 96 | 0.610 |
Why?
|
| Haemophilus influenzae | 4 | 2007 | 135 | 0.590 |
Why?
|
| Immunity, Innate | 5 | 2025 | 411 | 0.580 |
Why?
|
| Influenza, Human | 7 | 2024 | 703 | 0.540 |
Why?
|
| Bronchiolitis | 4 | 2021 | 124 | 0.510 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2021 | 1263 | 0.500 |
Why?
|
| Genome, Viral | 4 | 2025 | 155 | 0.490 |
Why?
|
| Virus Diseases | 4 | 2022 | 285 | 0.480 |
Why?
|
| Host-Pathogen Interactions | 3 | 2025 | 258 | 0.480 |
Why?
|
| Epithelial Cells | 4 | 2024 | 900 | 0.430 |
Why?
|
| Hospitalization | 9 | 2025 | 1939 | 0.420 |
Why?
|
| Rhinovirus | 3 | 2025 | 65 | 0.380 |
Why?
|
| Humans | 64 | 2025 | 131680 | 0.380 |
Why?
|
| Enterovirus Infections | 2 | 2024 | 48 | 0.370 |
Why?
|
| Antibodies, Neutralizing | 7 | 2023 | 517 | 0.360 |
Why?
|
| Viruses | 3 | 2024 | 118 | 0.360 |
Why?
|
| Phenotype | 1 | 2021 | 4516 | 0.340 |
Why?
|
| Seasons | 5 | 2024 | 333 | 0.340 |
Why?
|
| Genotype | 8 | 2025 | 2655 | 0.330 |
Why?
|
| Influenza A virus | 2 | 2015 | 149 | 0.330 |
Why?
|
| Immunity, Humoral | 2 | 2021 | 76 | 0.330 |
Why?
|
| Sindbis Virus | 1 | 2009 | 10 | 0.310 |
Why?
|
| Infant | 18 | 2025 | 13306 | 0.310 |
Why?
|
| Molecular Diagnostic Techniques | 3 | 2022 | 172 | 0.310 |
Why?
|
| Adult | 18 | 2025 | 31719 | 0.300 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2021 | 530 | 0.300 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2006 | 121 | 0.290 |
Why?
|
| Virus Shedding | 4 | 2021 | 75 | 0.290 |
Why?
|
| Streptococcus pneumoniae | 2 | 2007 | 389 | 0.270 |
Why?
|
| Drosophila Proteins | 2 | 2013 | 788 | 0.260 |
Why?
|
| Female | 27 | 2025 | 71186 | 0.250 |
Why?
|
| Parainfluenza Virus 3, Human | 1 | 2006 | 12 | 0.240 |
Why?
|
| Kinetics | 2 | 2025 | 1101 | 0.240 |
Why?
|
| Nucleosides | 1 | 2025 | 18 | 0.230 |
Why?
|
| Male | 22 | 2025 | 65267 | 0.230 |
Why?
|
| Viral Tropism | 1 | 2025 | 48 | 0.220 |
Why?
|
| Immunity, Mucosal | 2 | 2025 | 90 | 0.220 |
Why?
|
| Adenoviruses, Human | 1 | 2025 | 97 | 0.220 |
Why?
|
| Influenza Vaccines | 2 | 2023 | 500 | 0.220 |
Why?
|
| Adenovirus Infections, Human | 1 | 2025 | 60 | 0.220 |
Why?
|
| Nose | 1 | 2025 | 112 | 0.220 |
Why?
|
| Texas | 5 | 2023 | 3622 | 0.220 |
Why?
|
| Antigens, Viral | 3 | 2024 | 396 | 0.210 |
Why?
|
| Genetic Variation | 4 | 2025 | 1556 | 0.210 |
Why?
|
| Liposomes | 1 | 2025 | 200 | 0.210 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2024 | 15 | 0.210 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2024 | 60 | 0.210 |
Why?
|
| Antiviral Agents | 3 | 2025 | 812 | 0.210 |
Why?
|
| Immunoglobulin A | 2 | 2021 | 210 | 0.210 |
Why?
|
| Immunoglobulin G | 3 | 2021 | 810 | 0.210 |
Why?
|
| Pandemics | 6 | 2024 | 1164 | 0.200 |
Why?
|
| Acetamides | 1 | 2024 | 44 | 0.200 |
Why?
|
| Enterovirus | 1 | 2024 | 52 | 0.200 |
Why?
|
| Poliovirus | 1 | 2023 | 47 | 0.200 |
Why?
|
| Disease Outbreaks | 2 | 2023 | 314 | 0.200 |
Why?
|
| Up-Regulation | 1 | 2006 | 832 | 0.200 |
Why?
|
| Phylogeny | 5 | 2025 | 709 | 0.200 |
Why?
|
| Disease Susceptibility | 1 | 2024 | 283 | 0.190 |
Why?
|
| Cell Line | 5 | 2023 | 2605 | 0.190 |
Why?
|
| Child, Preschool | 13 | 2025 | 15057 | 0.190 |
Why?
|
| Caliciviridae Infections | 1 | 2025 | 289 | 0.190 |
Why?
|
| Lung | 3 | 2025 | 1565 | 0.180 |
Why?
|
| Norovirus | 1 | 2025 | 288 | 0.180 |
Why?
|
| Enterovirus D, Human | 1 | 2021 | 11 | 0.180 |
Why?
|
| Palivizumab | 2 | 2021 | 48 | 0.180 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 368 | 0.180 |
Why?
|
| Coinfection | 2 | 2021 | 192 | 0.180 |
Why?
|
| Respiratory Tract Diseases | 1 | 2022 | 80 | 0.170 |
Why?
|
| Viral Structural Proteins | 1 | 2021 | 39 | 0.170 |
Why?
|
| Sequence Analysis, DNA | 3 | 2024 | 1745 | 0.170 |
Why?
|
| Public Health Surveillance | 1 | 2020 | 44 | 0.170 |
Why?
|
| Prospective Studies | 8 | 2025 | 6494 | 0.170 |
Why?
|
| Child | 15 | 2025 | 26299 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 358 | 0.160 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1517 | 0.160 |
Why?
|
| Respiratory Sounds | 1 | 2021 | 79 | 0.160 |
Why?
|
| Middle Aged | 7 | 2025 | 28889 | 0.150 |
Why?
|
| Haemophilus | 1 | 2019 | 13 | 0.150 |
Why?
|
| Population Surveillance | 1 | 2021 | 397 | 0.150 |
Why?
|
| Viral Envelope Proteins | 1 | 2020 | 157 | 0.150 |
Why?
|
| Cities | 3 | 2024 | 53 | 0.150 |
Why?
|
| Orthomyxoviridae | 1 | 2019 | 50 | 0.150 |
Why?
|
| Laboratories | 1 | 2019 | 84 | 0.140 |
Why?
|
| Adolescent | 9 | 2025 | 20982 | 0.140 |
Why?
|
| Young Adult | 5 | 2021 | 10104 | 0.140 |
Why?
|
| Cross Infection | 1 | 2021 | 338 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 287 | 0.130 |
Why?
|
| Genes, Viral | 1 | 2017 | 155 | 0.130 |
Why?
|
| Pregnancy Complications | 1 | 2022 | 547 | 0.130 |
Why?
|
| CHO Cells | 2 | 2007 | 149 | 0.130 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2019 | 500 | 0.120 |
Why?
|
| Cricetinae | 2 | 2007 | 367 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 2019 | 326 | 0.120 |
Why?
|
| RNA, Messenger | 3 | 2020 | 2568 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 366 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 378 | 0.110 |
Why?
|
| Vaccination | 2 | 2023 | 1040 | 0.110 |
Why?
|
| Influenza B virus | 1 | 2015 | 102 | 0.110 |
Why?
|
| United States | 7 | 2025 | 11804 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1397 | 0.110 |
Why?
|
| Mutation | 2 | 2024 | 6177 | 0.110 |
Why?
|
| Bodily Secretions | 1 | 2014 | 8 | 0.110 |
Why?
|
| Animals | 9 | 2025 | 34375 | 0.110 |
Why?
|
| Nasopharynx | 3 | 2019 | 86 | 0.110 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 62 | 0.110 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2016 | 188 | 0.100 |
Why?
|
| Amino Acid Sequence | 2 | 2017 | 2564 | 0.100 |
Why?
|
| Caspases | 1 | 2014 | 157 | 0.100 |
Why?
|
| Aged | 5 | 2021 | 21261 | 0.100 |
Why?
|
| Microbiota | 1 | 2019 | 441 | 0.100 |
Why?
|
| Sequence Alignment | 1 | 2014 | 595 | 0.100 |
Why?
|
| Alphavirus | 1 | 2013 | 17 | 0.100 |
Why?
|
| Infant, Newborn | 6 | 2024 | 8589 | 0.100 |
Why?
|
| Sigmodontinae | 2 | 2025 | 44 | 0.100 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2013 | 38 | 0.100 |
Why?
|
| Immunocompromised Host | 1 | 2014 | 313 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 6925 | 0.090 |
Why?
|
| Acute Disease | 2 | 2025 | 1153 | 0.090 |
Why?
|
| Cattle | 2 | 2024 | 521 | 0.090 |
Why?
|
| Epidemiological Monitoring | 2 | 2024 | 69 | 0.090 |
Why?
|
| Antibody Formation | 2 | 2021 | 267 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 3 | 2015 | 1489 | 0.080 |
Why?
|
| Insect Viruses | 1 | 2009 | 5 | 0.080 |
Why?
|
| Organisms, Genetically Modified | 1 | 2009 | 11 | 0.080 |
Why?
|
| Disease Vectors | 1 | 2009 | 22 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 3616 | 0.080 |
Why?
|
| Haemophilus Infections | 2 | 2007 | 97 | 0.080 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 3834 | 0.070 |
Why?
|
| Molecular Typing | 2 | 2021 | 32 | 0.070 |
Why?
|
| Drosophila | 1 | 2013 | 795 | 0.070 |
Why?
|
| Virulence | 2 | 2006 | 271 | 0.070 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2006 | 117 | 0.070 |
Why?
|
| Cricetulus | 1 | 2007 | 88 | 0.070 |
Why?
|
| Islam | 1 | 2006 | 11 | 0.060 |
Why?
|
| Arabs | 1 | 2006 | 29 | 0.060 |
Why?
|
| Chromosomes, Human, Y | 1 | 2006 | 51 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2006 | 1018 | 0.060 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2006 | 30 | 0.060 |
Why?
|
| Mucins | 1 | 2006 | 69 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2018 | 810 | 0.060 |
Why?
|
| Oligonucleotide Probes | 1 | 2025 | 87 | 0.060 |
Why?
|
| Drug Resistance, Viral | 1 | 2025 | 56 | 0.060 |
Why?
|
| Pneumococcal Infections | 1 | 2007 | 279 | 0.060 |
Why?
|
| Administration, Intranasal | 1 | 2025 | 130 | 0.060 |
Why?
|
| Livestock | 1 | 2024 | 9 | 0.060 |
Why?
|
| Haplotypes | 1 | 2006 | 543 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2006 | 227 | 0.060 |
Why?
|
| Farmers | 1 | 2024 | 13 | 0.060 |
Why?
|
| Age Factors | 2 | 2025 | 2872 | 0.050 |
Why?
|
| Adenosine | 1 | 2025 | 124 | 0.050 |
Why?
|
| Influenza in Birds | 1 | 2024 | 27 | 0.050 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 58 | 0.050 |
Why?
|
| Birds | 1 | 2024 | 87 | 0.050 |
Why?
|
| Epoxy Compounds | 1 | 2024 | 19 | 0.050 |
Why?
|
| Mutation Rate | 1 | 2024 | 68 | 0.050 |
Why?
|
| Transfection | 1 | 2006 | 960 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2006 | 418 | 0.050 |
Why?
|
| Drosophila melanogaster | 1 | 2009 | 846 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2006 | 769 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2025 | 1833 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2006 | 300 | 0.050 |
Why?
|
| Protein Binding | 1 | 2007 | 1712 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2025 | 393 | 0.050 |
Why?
|
| Bacterial Capsules | 1 | 2003 | 42 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2025 | 709 | 0.050 |
Why?
|
| Adhesins, Bacterial | 1 | 2003 | 71 | 0.050 |
Why?
|
| Gastroenteritis | 1 | 2025 | 316 | 0.050 |
Why?
|
| Crystallography, X-Ray | 1 | 2024 | 365 | 0.050 |
Why?
|
| Pregnancy | 3 | 2022 | 7572 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2025 | 1021 | 0.050 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2022 | 34 | 0.050 |
Why?
|
| Coronavirus | 1 | 2022 | 27 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2023 | 3454 | 0.050 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2023 | 126 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 2143 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2023 | 132 | 0.050 |
Why?
|
| Paramyxoviridae Infections | 1 | 2022 | 50 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 49 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2003 | 199 | 0.050 |
Why?
|
| Sequence Analysis | 1 | 2021 | 51 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2025 | 292 | 0.050 |
Why?
|
| Peripartum Period | 1 | 2022 | 27 | 0.040 |
Why?
|
| Turbinates | 1 | 2021 | 13 | 0.040 |
Why?
|
| Water | 1 | 2023 | 190 | 0.040 |
Why?
|
| Immune Evasion | 1 | 2021 | 39 | 0.040 |
Why?
|
| Antibodies, Bacterial | 1 | 2024 | 427 | 0.040 |
Why?
|
| Gene Expression | 1 | 2006 | 1502 | 0.040 |
Why?
|
| Fever | 1 | 2024 | 311 | 0.040 |
Why?
|
| Species Specificity | 1 | 2022 | 519 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 420 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2021 | 200 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2021 | 146 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2021 | 436 | 0.040 |
Why?
|
| Public Health | 1 | 2023 | 277 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2024 | 657 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2990 | 0.040 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 2020 | 10 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2022 | 3101 | 0.040 |
Why?
|
| Antibody Affinity | 1 | 2020 | 42 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2006 | 2971 | 0.040 |
Why?
|
| Half-Life | 1 | 2020 | 151 | 0.040 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 49 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 146 | 0.040 |
Why?
|
| Outpatients | 1 | 2021 | 266 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2021 | 750 | 0.040 |
Why?
|
| RNA Stability | 1 | 2020 | 75 | 0.040 |
Why?
|
| Time Factors | 2 | 2020 | 6279 | 0.040 |
Why?
|
| DNA Probes | 1 | 2019 | 120 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 74 | 0.040 |
Why?
|
| Alanine | 1 | 2020 | 163 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2024 | 794 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 810 | 0.040 |
Why?
|
| Transcriptome | 1 | 2025 | 1163 | 0.040 |
Why?
|
| DNA Primers | 1 | 2019 | 609 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 3673 | 0.030 |
Why?
|
| Allografts | 1 | 2019 | 209 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2025 | 2463 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 1236 | 0.030 |
Why?
|
| Peptides | 1 | 2021 | 835 | 0.030 |
Why?
|
| Chile | 1 | 2017 | 25 | 0.030 |
Why?
|
| Antigenic Variation | 1 | 2017 | 37 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 1405 | 0.030 |
Why?
|
| Genomics | 1 | 2025 | 1625 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 1483 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2019 | 346 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2017 | 92 | 0.030 |
Why?
|
| Child, Hospitalized | 1 | 2017 | 79 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 410 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 226 | 0.030 |
Why?
|
| Nasal Cavity | 1 | 2015 | 55 | 0.030 |
Why?
|
| Vaccines, Inactivated | 1 | 2016 | 149 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 630 | 0.030 |
Why?
|
| Bacteria | 1 | 2019 | 532 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2015 | 149 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 4696 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 5123 | 0.030 |
Why?
|
| Incidence | 1 | 2021 | 3347 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2013 | 226 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 1010 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 3695 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1217 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 2297 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 4050 | 0.020 |
Why?
|
| Mice | 1 | 2025 | 18488 | 0.020 |
Why?
|
| Geography | 1 | 2006 | 119 | 0.020 |
Why?
|
| Asia | 1 | 2006 | 125 | 0.020 |
Why?
|
| India | 1 | 2006 | 245 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2006 | 232 | 0.010 |
Why?
|
| Genetics, Population | 1 | 2006 | 185 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 4952 | 0.010 |
Why?
|
| Biomarkers | 1 | 2014 | 3405 | 0.010 |
Why?
|
| Fimbriae Proteins | 1 | 2003 | 20 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2003 | 208 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 1405 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 10959 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2003 | 173 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2003 | 492 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 17667 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 944 | 0.010 |
Why?
|
| Prevalence | 1 | 2003 | 2694 | 0.010 |
Why?
|